Welcome to LookChem.com Sign In|Join Free
  • or
(R)-2-chloro-1-(3,4-dimethoxyphenyl)ethanol is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

117465-38-0

Post Buying Request

117465-38-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

117465-38-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 117465-38-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,7,4,6 and 5 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 117465-38:
(8*1)+(7*1)+(6*7)+(5*4)+(4*6)+(3*5)+(2*3)+(1*8)=130
130 % 10 = 0
So 117465-38-0 is a valid CAS Registry Number.

117465-38-0Relevant academic research and scientific papers

Highly enantioselective acylation of chlorohydrins using Amano AK lipase from P. fluorescens immobilized on silk fibroin-alginate spheres

Ferreira, Irlon M.,Nishimura, Rodolfo H.V.,Souza, Ana B. Dos A.,Clososki, Giuliano C.,Yoshioka, Sergio A.,Porto, André L.M.

supporting information, p. 5062 - 5065 (2015/01/09)

Aromatic, allylic, and aliphatic compounds containing a chlorohydrin group were selected as substrates for the enzymatic kinetic resolution mediated by Amano AK lipase from Pseudomonas fluorescens immobilized in silk friboin-alginate spheres. Thus, the en

X-ray crystallography and computational docking for the detection and development of protein-ligand interactions

Kershaw,Wright,Sharma,Antonyuk,Strange,Berry,O'Neill,Hasnain

, p. 569 - 575 (2013/07/28)

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterised by the selective dysfunction and death of the upper and lower motor neurons. Median survival rates are between 3 and 5 years after diagnosis. Mutations in the gene encoding Cu/Zn superoxide dismutase (SOD1) have been linked to a subset of familial forms of ALS (fALS). Herein, we describe a fragment- based drug discovery (FBDD) approach for the investigation of small molecule binding sites in SOD1. X-ray crystallography has been used as the primary screening method and has been shown to directly detect protein-ligand interactions which cannot be unambiguously identified using other biophysical methods. The structural requirements for effective binding at Trp32 are detailed for a series of quinazoline-containing compounds. The investigation of an additional site that binds a range of catecholamines and the use of computational modelling to assist fragment evolution is discussed. This study also highlights the importance of ligand solubility for successful Xray crystallographic campaigns in lead compound design.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 117465-38-0